A final analysis from the trial of the mRNA vaccine, which included 40,000 volunteers in Latin America and Europe, is expected in two to three weeks.
The US said Thursday that it will now devote $3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage.
Among health care system employees, there are considerable disparities in COVID-19 vaccination rates by race/ethnicity and occupation.
Some prison systems in the United States have been able to vaccinate high numbers of inmates against COVID-19.
China’s Sinovac COVID-19 vaccine has been approved for emergency use authorization in adults 18 years and older.
The BNT162b2 COVID-19 vaccine was reported having a favorable safety and side-effect profile for adolescents aged 12 to 15 years.
Two doses of the Pfizer and AstraZeneca COVID-19 vaccines are effective against the coronavirus variant first identified in India.
Vaccines approved for use in the US and Europe show protection against all of the more infectious coronavirus variants known to be circling the globe.